This information is intended for healthcare professionals in Europe and the Middle East
Objective: Understanding differences and similarities between pulmonary GvHD after HSCT and CLAD after lung transplantation, opportunities for improved pulmonary GvHD assessment and clinical efficacy of ECP in the setting of lung GvHD.
Register to the Therakos Institute to gain online access
to our live and on-demand webinars.
This is an educational programme run by Therakos (UK) Ltd, a Mallinckrodt Company
